SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AB Science Announces That FDA Authorization (IND) Has Been Granted for the Initiation of Its Phase 3 Study in Severe Asthma. Patient Recruitment Commences in the US